Chemical Works of Gedeon Richter Plc (RICHT.BD) stock analysis

In our weekly check, Chemical Works of Gedeon Richter Plc is graded A (A to F). Of 25 checks on debt, profit, cash flow and trend: 22 pass, warnings: 3, red flags: 0.

About Chemical Works of Gedeon Richter Plc

Chemical Works of Gedeon Richter Plc is a Healthcare company (Medical - Pharmaceuticals), listed on BUD as RICHT.BD.

What our checks show for RICHT.BD

Warning signs

• Revenue grew only 4.8% a year over the last 3 years.
• The stock has fallen as much as 51% from a peak. Would you have held through that?
• Thinly traded (about 203 thousand shares a day): buying and selling can move the price.

Strengths

• Debt is low: 0.01x equity.
• The net margin rose by 2.7 points over 5 years, to 24.8%.
• The gross margin is 67.5% and has risen by 12.2 points: pricing power is holding.
• Operating cash flow is 1.31x net profit: the profit arrives as real cash.
• Analysts expect earnings per share to grow about 14.3% a year over the next years.
• Analysts expect the net margin to improve by 4.9 points from today's 24.8%.

Next earnings report: 2026-11-10

Similar companies

DIVISLAB.NS · 4507.T · 7733.T · TORNTPHARM.NS · 4543.T · 4523.T

Questions

What grade does Chemical Works of Gedeon Richter Plc (RICHT.BD) have?

In our weekly check, Chemical Works of Gedeon Richter Plc is graded A (A to F). Of 25 checks on debt, profit, cash flow and trend: 22 pass, warnings: 3, red flags: 0. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of RICHT.BD stock?

This week's biggest flags for Chemical Works of Gedeon Richter Plc: Weak revenue growth, Deep past fall, Thinly traded. In total 3 of 25 checks show a warning or a red flag.

What does Chemical Works of Gedeon Richter Plc do?

Chemical Works of Gedeon Richter Plc is a Healthcare company (Medical - Pharmaceuticals), listed on BUD as RICHT.BD.

When does Chemical Works of Gedeon Richter Plc report earnings next?

The next earnings report is expected on 2026-11-10. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis